Increased protein carbonyl groups in the serum of patients affected by thalassemia major

Annals of Hematology

Volumn 85, Issue 8, 2006, Pages 520-522

  Trombetta, Domenico ^a   Gangemi, Sebastiano ^a,b   Saija, Antonella ^a   Minciullo, Paola Lucia ^a   Cimino, Francesco ^a   Cristani, Mariateresa ^a   Briuglia, Silvana ^a   Piraino, Basilia ^a   Isola, Stefania ^a   Salpietro, Carmelo Damiano ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; HEMOGLOBIN; LACTATE DEHYDROGENASE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BLOOD PROTEINS; CHILD; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN CARBONYLATION; SEVERITY OF ILLNESS INDEX;

EID: 33747815102     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-006-0115-3     Document Type: Article

References (9)

1. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A (2003) Protein carbonylation in human diseases. Trends Mol Med 9:169-176
2. Filosa A, Valgimigli L, Pedulli GF, Sapone A, Maggio A, Renda D, Scozzone C, malizia R, Pitrolo L, Lo Pinto C, Borsellino Z, Cuccia L, Capra M, Canestro D, Broccoli M, Soleti A, Paolini M (2005) Quantitative evaluation of oxidative stress status on peripheral blood in beta-thalassaemic patients by means of electron paramagnetic resonance spectroscopy. Br J Haematol 131:135-140
3. Gangemi S, Merendino RA, Meo A, Minciullo PL, Briglia S, Merlino MV, Rigoli L, Tomasello c, Sampietro CD (2003) Serum levels of interleukin-18 in splenectomized and nonsplenectomized thalassemic patients: Preliminary considerations. Acta Haematol 110:45-47
4. Haddad JJ (2002) Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal 14:879-897
5. Kassab-Chekir A, Laradi S, Ferchichi S, Hai Khelil A, Feki M, Amri F, Selmi H, bejaoui M, Miled A (2003) Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta 338:79-86
6. Kormoczi GF, Saemann MD, Buchta C, Peck-Radosavljevic M, Mayr WR, Schwartz DWM, Dunkler D, Spitzauer S, Panzer S (2006) Influence of clinical factors on the haemolysis marker haptoglobin. Eur J Clin Investig 36:202-209
7. Kumar S, Bandyopadhyay U (2005) Free heme toxicity and its detoxification systems in human. Toxicol Lett 157:175-188
8. Morabito F, Cristiani M, Saija A, Stelitano C, Callea V, Tomaino A, Minciullo PL, Gangemi S (2004) Lipid peroxidation and protein oxidation in patients affected by Hodgkin's lymphoma. Mediators Inflamm 13:381-383
9. Schrier SL, Centis F, Verneris M, Ma L, Angelucci E (2003) The role of oxidant injury in the pathophysiology of human thalassemias. Redox Rep 8:241-245